. 2025 May 30;25:267. doi: 10.1186/s12905-025-03829-6

Table 4.

Correlations of ULIFT Disease-specific-related and Functionality-related parameters (n = 36)

ULIFT	r/ rho	p-value
Severity of lymphedema (cm³)	0.707 ^a**	< 0.001
Duration of lymphedema (months)	0.456 ^b*	0.005
Range of Motion
Shoulder flexion	-0.452 ^a*	0.006
Shoulder abduction	-0.372 ^a*	0.025
Elbow flexion	-0.406 ^a*	0.014
Wrist flexion	-0.413 ^a*	0.012
Wrist extension	-0.355 ^a*	0.034
DASH
Disability/symptom score	0.395 ^a*	0.017
Work module score	0.385 ^a*	0.020
Hand grip (kg)	-0.542 ^a*	0.001
ULL-27
Physical score	0.432 ^a*	0.008
Psychological score	0.162^a	0.189
Social score	0.161^a	0.193
Global score	0.393 ^a*	0.018
SF-36
Physical functioning	-0.57 ^b*	0.008
Role limitations–physical	-0.461 ^b*	0.005
Role limitations–emotional	-0.140^b	0.417
Energy/vitality	-0.501^b	0.767
Mental health	-0.21^b	0.901
Social functioning	-0.27^b	0.830
Bodily pain	-0.471 ^b *	0.004
General health	− 0.416 ^b*	0.012

n: number, ULIFT: Upper Limb Functional Test, DASH: Disabilities of the Arm, Shoulder and Hand, ULL-27: Upper Limb Lymphedama 27 Questionnaire, SF-36: Medical Outcomes Study Short-Form 36, a: Pearson correlation coefficient, b: Spearmen correlation coefficient. *: p < 0.05, **p < 0.001